** Shares of Australia's Osteopore OSX.AX jump 40% to A$0.028, their highest level since mid-April 2025
** Regenerative medicine co expands its orthopaedic business into Hong Kong via an exclusive distribution agreement with MontsMed Hong Kong Company
** Business will initially focus on the orthopaedic trauma reconstruction market, a segment where co's devices have the highest likelihood of application
** Shares have more than quadrupled in value, YTD
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))